EP Patent

EP1858495A2 — Device for delivery of trpv1 agonists

Assigned to NeurogesX Inc · Expires 2007-11-28 · 18y expired

What this patent protects

Described here are drug delivery devices including an occlusive backing layer and a drug depot containing a TRJPVl agonist and a non-hydrophilic solvent. The drug depot may take various forms, such as an adhesive polymeric matrix, liquid reservoir, or microreservoir droplets. Met…

USPTO Abstract

Described here are drug delivery devices including an occlusive backing layer and a drug depot containing a TRJPVl agonist and a non-hydrophilic solvent. The drug depot may take various forms, such as an adhesive polymeric matrix, liquid reservoir, or microreservoir droplets. Methods of making and using the drug delivery devices are also described.

Drugs covered by this patent

Patent Metadata

Patent number
EP1858495A2
Jurisdiction
EP
Classification
—
Expires
2007-11-28
Drug substance claim
No
Drug product claim
No
Assignee
NeurogesX Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.